423. Rawlins M.D. Pathogenesis of ADR / M.D. Rawlins, J.W. Thompson //
Textbook on adverse drug reaction. - Oxford Univ Press, 1977. - P. 10-31
424. Reichman L.B. Multidrug resistance in the world: the present situation /
L.B. Reichman // Chemotherapy. - 1996. - Vol. 42, № 3. - P. 2-9.
425. Reichman L.B. Tuberculosis elimination - what to stop us? / L.B.
Reichman // Int. J. Tuberc. Lung Dis. - 1997. - Vol. 1, № 1. - P. 3-11.
426. Ridzon R. Asymptomatic hepatitis in persons who received alternative
preventive therapy with pyrazinamide and ofloxacin / R. Ridson, P. Meador //
Onorato Ida M. Clin. Infec. Diseases. 1997. - Vol. 24, № 6. - P. 1264-1265.
427. Ristic-Andelkov A. Aortic valve stenosis / A. Ristic-Andelkov, B.
Clinic, M. Damnjianovic et al. // Vojnosanit Pregl. - 2003. - Vol. 60. - P. 167-
174.
428. Rocha M. Does pulmonary tuberculosis change with ageing? / M.
Rocha // Int. J. Tuberc. Lung Dis. - 1997. - Vol. 1, № 2. - P. 147-151.
429. Rodriguez J.C. In vitro activity of four fluoroquinolones against
Mycobacterium tuberculosis / J.C. Rodriguez, M. Ruiz, A. Climent et al. // Intern.
J. Antimicrob. Ag. - 2001 .- Vol. 1 7 ,№ 3 . -P . 229-231.
430. Royer R.J. Mechanism of action of ADRs: an jverviev / R.J. Royer //
Pharmacoepidemiology and Drug Saf. - 1997. -№ 6, Suppl. 3. - P. 843-850.
431. Sack K. Side effects of aminoglycosides: neurotoxicity / K. Sack, H.
Freiesleben, B. Zullich et al. // Infection. - 1976. - Vol. 4, № 4. - P. 231-238.
432. Saito H. In Vitro activity and mutant selectivity of gatifloxacin against
Mycobacterium tuberculosis / H. Saito // 22 Intern. Congr. Chemother.,
Amsterdam, 2001; Abstracts: № S 11.05. In: Intern. J. Antimicrob. Ag. - 2001. -
№ 17 - Suppl. 1.
433. Saltini C. Advances in research and control tuberculosis / C. Saltini, J.
J.ivanyi // Eur. J. Respir. Dis. - 1995. - Vol. 8, № 9. - P. 1444.
434. Savula M.M. The effect of isoniazid and PAS on various biochemical
indices of liver function in patients with tuberculosis / M.M. Savula, I.N. Tytor //
Vrach. D e lo .- 1983. - № 7 . - P . 16-19.
402
